首页> 外文期刊>The journal of immunology >Two Structurally Different Rituximab-Specific CD20 Mimotope Peptides Reveal That Rituximab Recognizes Two Different CD20-Associated Epitopes
【24h】

Two Structurally Different Rituximab-Specific CD20 Mimotope Peptides Reveal That Rituximab Recognizes Two Different CD20-Associated Epitopes

机译:两种结构不同的利妥昔单抗特异性CD20拟肽多肽揭示了利妥昔单抗识别两个不同的CD20相关表位。

获取原文
       

摘要

Peptide mimotopes of the CD20 epitope recognized by rituximab are useful tools for studying this therapeutic mAb’s functional properties. We previously identified two structurally different peptides that are both effective mimotopes: a 7-mer cyclic peptide (Rp15-C) bearing the antigenic motif ![Graphic][1]/imga/sNPS![Graphic][2]/img that matches 170![Graphic][3]/imgANPS![Graphic][4]/img173 of the extracellular loop of CD20, and a 12-mer linear peptide (Rp5-L) containing the antigenic motif ![Graphic][5]/imgWPxWLE![Graphic][6]/img lacking sequence homology to CD20. In this study, we investigated whether the different structures of Rp15-C and Rp5-L reflect the mimicry of the same or different CD20 epitopes recognized by rituximab. Using immunochemical methods, we found that, like Rp15-C, Rp5-L mimics the raft-associated form of CD20 (by inhibiting rituximab binding to CD20 in vitro). Rp5-L and Rp15-C elicit, in immunized mice, anti-CD20 Abs that stain CD20+ cells with a punctate pattern similar to that of rituximab. However, only anti-Rp5-L Abs recognize denatured CD20. When phage-display peptide libraries were panned with anti-Rp5-L, phage clones were enriched that expressed the consensus qWPxwL, similar to the antigenic motif ![Graphic][7]/imgWPxWLE![Graphic][8]/img, but not matching ![Graphic][9]/imga/sNPS![Graphic][10]/img. Finally, ![Graphic][11]/imgWPxWLE![Graphic][12]/img and ![Graphic][13]/imgANPS![Graphic][14]/img share some, but not all, contact sites within the rituximab Ag-combining site, indicating that ![Graphic][15]/imgWPxWLE![Graphic][16]/img is not an exact replica of Rp15-C (or CD20) ![Graphic][17]/imgANPS![Graphic][18]/img. Altogether, these results indicate that the two structurally different peptides are also conformationally different, and suggest that rituximab recognizes two different CD20-associated epitopes. [1]: /embed/inline-graphic-1.gif [2]: /embed/inline-graphic-2.gif [3]: /embed/inline-graphic-3.gif [4]: /embed/inline-graphic-4.gif [5]: /embed/inline-graphic-5.gif [6]: /embed/inline-graphic-6.gif [7]: /embed/inline-graphic-7.gif [8]: /embed/inline-graphic-8.gif [9]: /embed/inline-graphic-9.gif [10]: /embed/inline-graphic-10.gif [11]: /embed/inline-graphic-11.gif [12]: /embed/inline-graphic-12.gif [13]: /embed/inline-graphic-13.gif [14]: /embed/inline-graphic-14.gif [15]: /embed/inline-graphic-15.gif [16]: /embed/inline-graphic-16.gif [17]: /embed/inline-graphic-17.gif [18]: /embed/inline-graphic-18.gif
机译:利妥昔单抗识别的CD20表位的肽模拟表位是研究这种治疗性mAb功能特性的有用工具。我们先前鉴定了两种结构上均有效的拟态肽:具有抗原基序![Graphic] [1] a / sNPS![Graphic] [2]的7-mer环肽(Rp15-C)< / img>匹配CD20胞外环的170![Graphic] [3] ANPS![Graphic] [4] 173和包含12个单体的线性肽(Rp5-L)抗原基序![Graphic] [5] WPxWLE![Graphic] [6] 与CD20缺乏序列同源性。在这项研究中,我们调查了Rp15-C和Rp5-L的不同结构是否反映了利妥昔单抗识别的相同或不同CD20表位的拟态。使用免疫化学方法,我们发现,与Rp15-C一样,Rp5-L模拟了筏相关形式的CD20(通过在体外抑制利妥昔单抗与CD20的结合)。在免疫小鼠中,Rp5-L和Rp15-C引发抗CD20 Abs,该CD20 Abs以类似于利妥昔单抗的点状模式染色CD20 +细胞。但是,只有抗Rp5-L抗体可识别变性的CD20。当用抗Rp5-L淘选噬菌体展示肽文库时,富集了表达共有qWPxwL的噬菌体克隆,类似于抗原基序![Graphic] [7] WPxWLE![Graphic] [8] < / img>,但不匹配![Graphic] [9] a / sNPS![Graphic] [10] 。最后,![Graphic] [11] WPxWLE![Graphic] [12] 和![Graphic] [13] ANPS![Graphic] [14] 分享rituximab Ag合并位点中的一些但不是全部接触点,表明![Graphic] [15] WPxWLE![Graphic] [16] 不是Rp15-C的精确副本(或CD20)![Graphic] [17] ANPS![Graphic] [18] 。总而言之,这些结果表明两种结构上不同的肽在构象上也不同,并且表明利妥昔单抗识别两种不同的CD20相关的表位。 [1]:/embed/inline-graphic-1.gif [2]:/embed/inline-graphic-2.gif [3]:/embed/inline-graphic-3.gif [4]:/ embed / inline -graphic-4.gif [5]:/embed/inline-graphic-5.gif [6]:/embed/inline-graphic-6.gif [7]:/embed/inline-graphic-7.gif [8] ]:/embed/inline-graphic-8.gif [9]:/embed/inline-graphic-9.gif [10]:/embed/inline-graphic-10.gif [11]:/embed/inline-graphic-8.gif -11.gif [12]:/embed/inline-graphic-12.gif [13]:/embed/inline-graphic-13.gif [14]:/embed/inline-graphic-14.gif [15]: /embed/inline-graphic-15.gif [16]:/embed/inline-graphic-16.gif [17]:/embed/inline-graphic-17.gif [18]:/ embed / inline-graphic-18 .gif

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号